In the early streptozotocin-induced diabetic retinopathy model, an increase in Ang2 levels led to astrocyte loss and vascular leakage, both of which were blocked by intravitreal injection of an Ang2-neutralizing antibody [101]. Here, ANGPT2 is linked to diabetic retinopathy.